nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—Pleuritic pain—Bleomycin—lymphatic system cancer	0.0454	0.0454	CcSEcCtD
Danazol—Thrombosis—Mechlorethamine—lymphatic system cancer	0.0271	0.0271	CcSEcCtD
Danazol—Guillain-Barre syndrome—Methotrexate—lymphatic system cancer	0.0254	0.0254	CcSEcCtD
Danazol—Amenorrhoea—Mechlorethamine—lymphatic system cancer	0.0218	0.0218	CcSEcCtD
Danazol—Seborrhoeic dermatitis—Fludarabine—lymphatic system cancer	0.0182	0.0182	CcSEcCtD
Danazol—Interstitial pneumonia—Mitoxantrone—lymphatic system cancer	0.0153	0.0153	CcSEcCtD
Danazol—Epigastric pain—Mitoxantrone—lymphatic system cancer	0.0153	0.0153	CcSEcCtD
Danazol—Arterial thrombosis—Methotrexate—lymphatic system cancer	0.0137	0.0137	CcSEcCtD
Danazol—Interstitial lung disease—Bleomycin—lymphatic system cancer	0.0129	0.0129	CcSEcCtD
Danazol—Nodule—Methotrexate—lymphatic system cancer	0.0125	0.0125	CcSEcCtD
Danazol—Hepatic function abnormal—Teniposide—lymphatic system cancer	0.0118	0.0118	CcSEcCtD
Danazol—Interstitial lung disease—Carmustine—lymphatic system cancer	0.0112	0.0112	CcSEcCtD
Danazol—Thrombosis—Carmustine—lymphatic system cancer	0.0112	0.0112	CcSEcCtD
Danazol—Jaundice—Mechlorethamine—lymphatic system cancer	0.0105	0.0105	CcSEcCtD
Danazol—Interstitial lung disease—Mitoxantrone—lymphatic system cancer	0.0105	0.0105	CcSEcCtD
Danazol—Sleep disorder—Fludarabine—lymphatic system cancer	0.0104	0.0104	CcSEcCtD
Danazol—Haemoglobin—Mechlorethamine—lymphatic system cancer	0.00969	0.00969	CcSEcCtD
Danazol—Haemorrhage—Mechlorethamine—lymphatic system cancer	0.00964	0.00964	CcSEcCtD
Danazol—Visual disturbance—Fludarabine—lymphatic system cancer	0.00953	0.00953	CcSEcCtD
Danazol—Erythema multiforme—Mechlorethamine—lymphatic system cancer	0.00911	0.00911	CcSEcCtD
Danazol—Alopecia—Mechlorethamine—lymphatic system cancer	0.00852	0.00852	CcSEcCtD
Danazol—Leukocytosis—Carmustine—lymphatic system cancer	0.00847	0.00847	CcSEcCtD
Danazol—Amenorrhoea—Mitoxantrone—lymphatic system cancer	0.00842	0.00842	CcSEcCtD
Danazol—Interstitial pneumonia—Methotrexate—lymphatic system cancer	0.00763	0.00763	CcSEcCtD
Danazol—Sweating—Teniposide—lymphatic system cancer	0.00759	0.00759	CcSEcCtD
Danazol—Vertigo—Mechlorethamine—lymphatic system cancer	0.00754	0.00754	CcSEcCtD
Danazol—Leukopenia—Mechlorethamine—lymphatic system cancer	0.00751	0.00751	CcSEcCtD
Danazol—Haemoglobin—Teniposide—lymphatic system cancer	0.00714	0.00714	CcSEcCtD
Danazol—Haemorrhage—Teniposide—lymphatic system cancer	0.00711	0.00711	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Fludarabine—lymphatic system cancer	0.0069	0.0069	CcSEcCtD
Danazol—Acute coronary syndrome—Fludarabine—lymphatic system cancer	0.00686	0.00686	CcSEcCtD
Danazol—Myocardial infarction—Fludarabine—lymphatic system cancer	0.00682	0.00682	CcSEcCtD
Danazol—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00671	0.00671	CcSEcCtD
Danazol—Haematuria—Fludarabine—lymphatic system cancer	0.00663	0.00663	CcSEcCtD
Danazol—Flushing—Teniposide—lymphatic system cancer	0.0066	0.0066	CcSEcCtD
Danazol—Chills—Teniposide—lymphatic system cancer	0.00638	0.00638	CcSEcCtD
Danazol—Alopecia—Teniposide—lymphatic system cancer	0.00628	0.00628	CcSEcCtD
Danazol—Haemoglobin—Fludarabine—lymphatic system cancer	0.00628	0.00628	CcSEcCtD
Danazol—Haemorrhage—Fludarabine—lymphatic system cancer	0.00625	0.00625	CcSEcCtD
Danazol—Visual impairment—Fludarabine—lymphatic system cancer	0.00602	0.00602	CcSEcCtD
Danazol—Erythema multiforme—Fludarabine—lymphatic system cancer	0.00591	0.00591	CcSEcCtD
Danazol—Chills—Fludarabine—lymphatic system cancer	0.0056	0.0056	CcSEcCtD
Danazol—Leukopenia—Teniposide—lymphatic system cancer	0.00554	0.00554	CcSEcCtD
Danazol—Alopecia—Fludarabine—lymphatic system cancer	0.00552	0.00552	CcSEcCtD
Danazol—Hypertension—Teniposide—lymphatic system cancer	0.00534	0.00534	CcSEcCtD
Danazol—Interstitial lung disease—Methotrexate—lymphatic system cancer	0.00521	0.00521	CcSEcCtD
Danazol—Oedema—Teniposide—lymphatic system cancer	0.00505	0.00505	CcSEcCtD
Danazol—Acute coronary syndrome—Bleomycin—lymphatic system cancer	0.00503	0.00503	CcSEcCtD
Danazol—Myocardial infarction—Bleomycin—lymphatic system cancer	0.005	0.005	CcSEcCtD
Danazol—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00494	0.00494	CcSEcCtD
Danazol—Tachycardia—Teniposide—lymphatic system cancer	0.00493	0.00493	CcSEcCtD
Danazol—Abdominal pain upper—Mitoxantrone—lymphatic system cancer	0.00491	0.00491	CcSEcCtD
Danazol—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00488	0.00488	CcSEcCtD
Danazol—Leukopenia—Fludarabine—lymphatic system cancer	0.00487	0.00487	CcSEcCtD
Danazol—Haematuria—Bleomycin—lymphatic system cancer	0.00486	0.00486	CcSEcCtD
Danazol—Pruritus—Mechlorethamine—lymphatic system cancer	0.00485	0.00485	CcSEcCtD
Danazol—Convulsion—Fludarabine—lymphatic system cancer	0.00471	0.00471	CcSEcCtD
Danazol—Arthralgia—Fludarabine—lymphatic system cancer	0.00463	0.00463	CcSEcCtD
Danazol—Haemoglobin—Bleomycin—lymphatic system cancer	0.0046	0.0046	CcSEcCtD
Danazol—Haemorrhage—Bleomycin—lymphatic system cancer	0.00458	0.00458	CcSEcCtD
Danazol—Oedema—Fludarabine—lymphatic system cancer	0.00444	0.00444	CcSEcCtD
Danazol—Vomiting—Mechlorethamine—lymphatic system cancer	0.00435	0.00435	CcSEcCtD
Danazol—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.00435	0.00435	CcSEcCtD
Danazol—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00434	0.00434	CcSEcCtD
Danazol—Rash—Mechlorethamine—lymphatic system cancer	0.00432	0.00432	CcSEcCtD
Danazol—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00431	0.00431	CcSEcCtD
Danazol—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00429	0.00429	CcSEcCtD
Danazol—Flushing—Bleomycin—lymphatic system cancer	0.00425	0.00425	CcSEcCtD
Danazol—Weight increased—Mitoxantrone—lymphatic system cancer	0.00423	0.00423	CcSEcCtD
Danazol—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.00419	0.00419	CcSEcCtD
Danazol—Myocardial infarction—Vincristine—lymphatic system cancer	0.00417	0.00417	CcSEcCtD
Danazol—Chills—Bleomycin—lymphatic system cancer	0.00411	0.00411	CcSEcCtD
Danazol—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.00408	0.00408	CcSEcCtD
Danazol—Sweating—Vincristine—lymphatic system cancer	0.00407	0.00407	CcSEcCtD
Danazol—Nausea—Mechlorethamine—lymphatic system cancer	0.00407	0.00407	CcSEcCtD
Danazol—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.00406	0.00406	CcSEcCtD
Danazol—Alopecia—Bleomycin—lymphatic system cancer	0.00405	0.00405	CcSEcCtD
Danazol—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00404	0.00404	CcSEcCtD
Danazol—Jaundice—Mitoxantrone—lymphatic system cancer	0.00403	0.00403	CcSEcCtD
Danazol—Haemoglobin—Carmustine—lymphatic system cancer	0.00402	0.00402	CcSEcCtD
Danazol—Urticaria—Teniposide—lymphatic system cancer	0.00401	0.00401	CcSEcCtD
Danazol—Haemorrhage—Carmustine—lymphatic system cancer	0.004	0.004	CcSEcCtD
Danazol—Body temperature increased—Teniposide—lymphatic system cancer	0.00399	0.00399	CcSEcCtD
Danazol—Paraesthesia—Fludarabine—lymphatic system cancer	0.00398	0.00398	CcSEcCtD
Danazol—Sweating—Mitoxantrone—lymphatic system cancer	0.00397	0.00397	CcSEcCtD
Danazol—Haematuria—Mitoxantrone—lymphatic system cancer	0.00395	0.00395	CcSEcCtD
Danazol—Dyspepsia—Fludarabine—lymphatic system cancer	0.00391	0.00391	CcSEcCtD
Danazol—Visual impairment—Carmustine—lymphatic system cancer	0.00385	0.00385	CcSEcCtD
Danazol—Fatigue—Fludarabine—lymphatic system cancer	0.00383	0.00383	CcSEcCtD
Danazol—Constipation—Fludarabine—lymphatic system cancer	0.00379	0.00379	CcSEcCtD
Danazol—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00373	0.00373	CcSEcCtD
Danazol—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00372	0.00372	CcSEcCtD
Danazol—Flushing—Carmustine—lymphatic system cancer	0.00371	0.00371	CcSEcCtD
Danazol—Asthenia—Teniposide—lymphatic system cancer	0.00362	0.00362	CcSEcCtD
Danazol—Pruritus—Teniposide—lymphatic system cancer	0.00357	0.00357	CcSEcCtD
Danazol—Leukopenia—Bleomycin—lymphatic system cancer	0.00357	0.00357	CcSEcCtD
Danazol—Alopecia—Carmustine—lymphatic system cancer	0.00353	0.00353	CcSEcCtD
Danazol—Body temperature increased—Fludarabine—lymphatic system cancer	0.00351	0.00351	CcSEcCtD
Danazol—Alopecia—Vincristine—lymphatic system cancer	0.00337	0.00337	CcSEcCtD
Danazol—Back pain—Carmustine—lymphatic system cancer	0.00337	0.00337	CcSEcCtD
Danazol—Chills—Mitoxantrone—lymphatic system cancer	0.00333	0.00333	CcSEcCtD
Danazol—Alopecia—Mitoxantrone—lymphatic system cancer	0.00328	0.00328	CcSEcCtD
Danazol—Vision blurred—Carmustine—lymphatic system cancer	0.00328	0.00328	CcSEcCtD
Danazol—Tremor—Carmustine—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Danazol—Oedema—Bleomycin—lymphatic system cancer	0.00325	0.00325	CcSEcCtD
Danazol—Back pain—Vincristine—lymphatic system cancer	0.00321	0.00321	CcSEcCtD
Danazol—Vomiting—Teniposide—lymphatic system cancer	0.00321	0.00321	CcSEcCtD
Danazol—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Danazol—Asthenia—Fludarabine—lymphatic system cancer	0.00318	0.00318	CcSEcCtD
Danazol—Rash—Teniposide—lymphatic system cancer	0.00318	0.00318	CcSEcCtD
Danazol—Dermatitis—Teniposide—lymphatic system cancer	0.00318	0.00318	CcSEcCtD
Danazol—Headache—Teniposide—lymphatic system cancer	0.00316	0.00316	CcSEcCtD
Danazol—Pruritus—Fludarabine—lymphatic system cancer	0.00314	0.00314	CcSEcCtD
Danazol—Back pain—Mitoxantrone—lymphatic system cancer	0.00313	0.00313	CcSEcCtD
Danazol—Leukopenia—Carmustine—lymphatic system cancer	0.00311	0.00311	CcSEcCtD
Danazol—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00305	0.00305	CcSEcCtD
Danazol—Photosensitivity—Methotrexate—lymphatic system cancer	0.00305	0.00305	CcSEcCtD
Danazol—Convulsion—Carmustine—lymphatic system cancer	0.00301	0.00301	CcSEcCtD
Danazol—Hypertension—Carmustine—lymphatic system cancer	0.003	0.003	CcSEcCtD
Danazol—Nausea—Teniposide—lymphatic system cancer	0.003	0.003	CcSEcCtD
Danazol—Vertigo—Vincristine—lymphatic system cancer	0.00298	0.00298	CcSEcCtD
Danazol—Leukopenia—Vincristine—lymphatic system cancer	0.00297	0.00297	CcSEcCtD
Danazol—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00296	0.00296	CcSEcCtD
Danazol—Anxiety—Carmustine—lymphatic system cancer	0.00295	0.00295	CcSEcCtD
Danazol—Paraesthesia—Bleomycin—lymphatic system cancer	0.00292	0.00292	CcSEcCtD
Danazol—Leukopenia—Mitoxantrone—lymphatic system cancer	0.0029	0.0029	CcSEcCtD
Danazol—Convulsion—Vincristine—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Danazol—Hypertension—Vincristine—lymphatic system cancer	0.00287	0.00287	CcSEcCtD
Danazol—Oedema—Carmustine—lymphatic system cancer	0.00284	0.00284	CcSEcCtD
Danazol—Visual disturbance—Methotrexate—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Danazol—Vomiting—Fludarabine—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Danazol—Convulsion—Mitoxantrone—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Danazol—Rash—Fludarabine—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Danazol—Dermatitis—Fludarabine—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Danazol—Hypertension—Mitoxantrone—lymphatic system cancer	0.00279	0.00279	CcSEcCtD
Danazol—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Danazol—Headache—Fludarabine—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Danazol—Tachycardia—Carmustine—lymphatic system cancer	0.00277	0.00277	CcSEcCtD
Danazol—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00275	0.00275	CcSEcCtD
Danazol—Anxiety—Mitoxantrone—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Danazol—Oedema—Vincristine—lymphatic system cancer	0.00271	0.00271	CcSEcCtD
Danazol—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00265	0.00265	CcSEcCtD
Danazol—Oedema—Mitoxantrone—lymphatic system cancer	0.00264	0.00264	CcSEcCtD
Danazol—Nausea—Fludarabine—lymphatic system cancer	0.00264	0.00264	CcSEcCtD
Danazol—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00262	0.00262	CcSEcCtD
Danazol—Shock—Mitoxantrone—lymphatic system cancer	0.0026	0.0026	CcSEcCtD
Danazol—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00259	0.00259	CcSEcCtD
Danazol—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00258	0.00258	CcSEcCtD
Danazol—Urticaria—Bleomycin—lymphatic system cancer	0.00258	0.00258	CcSEcCtD
Danazol—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00258	0.00258	CcSEcCtD
Danazol—Body temperature increased—Bleomycin—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Danazol—Irritability—Methotrexate—lymphatic system cancer	0.00255	0.00255	CcSEcCtD
Danazol—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00255	0.00255	CcSEcCtD
Danazol—Paraesthesia—Carmustine—lymphatic system cancer	0.00255	0.00255	CcSEcCtD
Danazol—Mood swings—Methotrexate—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Danazol—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00247	0.00247	CcSEcCtD
Danazol—Paraesthesia—Vincristine—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Danazol—Constipation—Carmustine—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Danazol—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Danazol—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Danazol—Fatigue—Vincristine—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Danazol—Asthenia—Bleomycin—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Danazol—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Danazol—Constipation—Vincristine—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Danazol—Pruritus—Bleomycin—lymphatic system cancer	0.0023	0.0023	CcSEcCtD
Danazol—Eosinophilia—Methotrexate—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Danazol—Fatigue—Mitoxantrone—lymphatic system cancer	0.00228	0.00228	CcSEcCtD
Danazol—Pancreatitis—Methotrexate—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Danazol—Constipation—Mitoxantrone—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Danazol—Body temperature increased—Carmustine—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Danazol—Body temperature increased—Vincristine—lymphatic system cancer	0.00214	0.00214	CcSEcCtD
Danazol—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Danazol—Urticaria—Mitoxantrone—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Danazol—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00209	0.00209	CcSEcCtD
Danazol—Vomiting—Bleomycin—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Danazol—Rash—Bleomycin—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Danazol—Dermatitis—Bleomycin—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.00204	0.00204	CcSEcCtD
Danazol—Asthenia—Carmustine—lymphatic system cancer	0.00204	0.00204	CcSEcCtD
Danazol—Sweating—Methotrexate—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Danazol—Haematuria—Methotrexate—lymphatic system cancer	0.00197	0.00197	CcSEcCtD
Danazol—Asthenia—Vincristine—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Danazol—Nausea—Bleomycin—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Danazol—Asthenia—Mitoxantrone—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Danazol—Dizziness—Carmustine—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Danazol—Haemoglobin—Methotrexate—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Danazol—Haemorrhage—Methotrexate—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Danazol—Vomiting—Carmustine—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Danazol—Dizziness—Vincristine—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Danazol—Rash—Carmustine—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Danazol—Dermatitis—Carmustine—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Danazol—Visual impairment—Methotrexate—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Danazol—Headache—Carmustine—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Danazol—Erythema multiforme—Methotrexate—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Danazol—Vomiting—Vincristine—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Danazol—Rash—Vincristine—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Danazol—Dermatitis—Vincristine—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Danazol—Headache—Vincristine—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Danazol—Nausea—Carmustine—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Danazol—Vomiting—Mitoxantrone—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Danazol—Rash—Mitoxantrone—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Danazol—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Danazol—Chills—Methotrexate—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Danazol—Headache—Mitoxantrone—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Danazol—Alopecia—Methotrexate—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Danazol—Nausea—Vincristine—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Danazol—Nausea—Mitoxantrone—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Danazol—Back pain—Methotrexate—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Danazol—Vision blurred—Methotrexate—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Danazol—Vertigo—Methotrexate—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Danazol—Leukopenia—Methotrexate—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Danazol—Convulsion—Methotrexate—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Danazol—Arthralgia—Methotrexate—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Danazol—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Danazol—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Danazol—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Danazol—Paraesthesia—Methotrexate—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Danazol—Dyspepsia—Methotrexate—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Danazol—Fatigue—Methotrexate—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Danazol—Urticaria—Methotrexate—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Danazol—Body temperature increased—Methotrexate—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Danazol—Asthenia—Methotrexate—lymphatic system cancer	0.000944	0.000944	CcSEcCtD
Danazol—Pruritus—Methotrexate—lymphatic system cancer	0.000931	0.000931	CcSEcCtD
Danazol—Dizziness—Methotrexate—lymphatic system cancer	0.00087	0.00087	CcSEcCtD
Danazol—Vomiting—Methotrexate—lymphatic system cancer	0.000836	0.000836	CcSEcCtD
Danazol—Rash—Methotrexate—lymphatic system cancer	0.000829	0.000829	CcSEcCtD
Danazol—Dermatitis—Methotrexate—lymphatic system cancer	0.000829	0.000829	CcSEcCtD
Danazol—Headache—Methotrexate—lymphatic system cancer	0.000824	0.000824	CcSEcCtD
Danazol—Nausea—Methotrexate—lymphatic system cancer	0.000781	0.000781	CcSEcCtD
